Product image of Pantoprazol Apharma (Pantoprazole) supplied by GNH India

Pantoprazol Apharma

Active Ingredient:
Pantoprazole
Origin:
EU

Pantoprazol Apharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Apharma, is a proton pump inhibitor presented as an injectable solution for intravenous use. It treats conditions such as gastro‑oesophageal reflux disease, erosive esophagitis and Zollinger‑Ellison syndrome in patients who require rapid acid suppression.

GNH India supplies Pantoprazol Apharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Manufacturer / TM Owner

Apta Medica Internacional D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazol Apharma is a proton pump inhibitor used in the management of acid‑related gastrointestinal disorders.

  • Erosive esophagitis: promotes healing of the esophageal lining by reducing gastric acid exposure.
  • Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and prevents damage to the esophagus.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
  • Prevention of NSAID‑induced gastric ulcers: reduces risk of ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs.

How It Works

  • Pantoprazole irreversibly binds to the H+/K+‑ATPase enzyme (gastric proton pump) on the secretory surface of parietal cells, blocking the final step of acid production. This inhibition markedly lowers gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Side Effects

Pantoprazol Apharma may be associated with a range of adverse reactions.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhea: usually self‑limiting.
  • Nausea: occasional and transient.
  • Abdominal pain: mild discomfort.
  • Flatulence: increased intestinal gas.
  • Dizziness: occasional light‑headedness.

Serious or Rare Side Effects

  • Clostridioides difficile infection: severe colitis risk.
  • Acute interstitial nephritis: kidney inflammation.
  • Severe hypersensitivity reactions: rash, angioedema, anaphylaxis.
  • Hepatotoxicity: elevated liver enzymes or liver injury.
  • Osteoporotic fractures: increased risk with long‑term use.
  • Thromboembolic events: rare clot formation.

Precautions & Warnings

Before initiating therapy with Pantoprazol Apharma, consider the following safety measures:

  • Assess renal function: adjust use in severe renal impairment.
  • Monitor electrolytes: watch for low magnesium and potassium levels.
  • Evaluate hepatic status: use cautiously in liver disease.
  • Review concomitant medications: potential for drug‑drug interactions.
  • Pregnancy and lactation: risk unknown, weigh benefits against risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Pantoprazole can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Antifungal azoles (e.g., ketoconazole): decreased absorption due to higher gastric pH.
  • Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
  • Atorvastatin: increased plasma concentration, raising myopathy risk.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential alteration of INR.
  • Methotrexate: increased serum levels, especially in renal impairment.
  • Digoxin: higher serum concentrations may occur.

Frequently Asked Questions

Pantoprazol Apharma is an intravenous proton pump inhibitor indicated for rapid reduction of gastric acid in conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome and for preventing NSAID‑induced gastric ulcers in hospitalized patients.

Pantoprazole irreversibly inhibits the H+/K+‑ATPase (gastric proton pump) on parietal cells, blocking the final step of acid secretion. This results in a sustained decrease in gastric acidity, facilitating mucosal healing and symptom control.

The prescribed dose of Pantoprazol Apharma is determined by the treating physician based on the patient’s condition, severity, and clinical response. Dosing regimens are individualized and should follow the prescriber’s instructions.

Safety data for pantoprazole in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Pantoprazol Apharma, as an IV proton pump inhibitor, offers faster and more consistent acid suppression than oral PPIs or H2‑receptor antagonists, making it suitable for acute care settings where rapid control of gastric acidity is required.

The product should be stored at 2‑8°C, protected from light, and must not be frozen or shaken. Keep the solution in its original packaging until use to maintain stability.

Pantoprazol Apharma is given as an intravenous infusion, typically diluted in a compatible IV fluid and administered over a few minutes under medical supervision, following the prescribing clinician’s instructions.

Serious risks include Clostridioides difficile‑associated colitis, acute interstitial nephritis, severe hypersensitivity reactions such as anaphylaxis, hepatotoxicity, and rare thromboembolic events. Patients should be monitored for these events during therapy.

Patients with known hypersensitivity to pantoprazole or any component of the injectable formulation should avoid its use. Caution is also advised for individuals with severe liver disease, uncontrolled infections, or those taking medications that have major interactions listed above.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT